tykhr
sign in
free sign up
TRACON Pharmaceuticals Inc
Biotechnology
Healthcare
TCON
20.92 M shares
NASDAQ US
traded
21 Apr 2023
listed
yes
open
1.72
52 week high
2.86
high
1.80
52 week low
1.32
low
1.70
growth
-11.44 %
previous Close
1.78
P/E ratio
market cap
30.85 M
div yield
0
usd
Sep 2022
qoq
revenue
0.00 %
net incoming
-6.44 M
-3.29 %
eps
0.00 %
3.23 %
eps surprise
-7.14 %
net profit margin
-643500000.00 %
0.00 %
operating incoming
-6.38 M
-2.21 %
net change in cash
3.63 M
218.69 %
cash on hand
17.04 M
25.46 %
cost of revenue
0.00 %
top